BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23913599)

  • 1. Invasive thoughts: honoring two decades of alcohol septal ablation for hypertrophic cardiomyopathy.
    Naidu SS
    J Invasive Cardiol; 2013 Aug; 25(8):369-70. PubMed ID: 23913599
    [No Abstract]   [Full Text] [Related]  

  • 2. Low alcohol tolerance--a blessing for septal ablation.
    Kimmelstiel C; Kapur NK
    Catheter Cardiovasc Interv; 2014 Jul; 84(1):108-9. PubMed ID: 24975263
    [No Abstract]   [Full Text] [Related]  

  • 3. Septal alcohol ablation in hypertrophic obstructive cardiomyopathy: improving cardiac function by generating a myocardial scar.
    Efthimiadis GK; Mezilis NE; Giannakoulas G; Parcharidis GE
    Eur Heart J; 2007 May; 28(10):1270-1; author reply 1271. PubMed ID: 17463007
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Sorajja P; Binder J; Nishimura RA; Holmes DR; Rihal CS; Gersh BJ; Bresnahan JF; Ommen SR
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):E58-67. PubMed ID: 22511295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying the target septal perforator prior to alcohol septal ablation in hypertrophic obstructive cardiomyopathy: a new application for computed tomography coronary angiography.
    Spratt JC; Langrish JP
    Heart; 2011 Oct; 97(20):1718-9. PubMed ID: 21807658
    [No Abstract]   [Full Text] [Related]  

  • 7. Early outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a European multicenter and multinational study.
    Veselka J; Lawrenz T; Stellbrink C; Zemanek D; Branny M; Januska J; Sitar J; Dimitrow P; Krejci J; Dabrowski M; Mizera S; Bartel T; Kuhn H
    Catheter Cardiovasc Interv; 2014 Jul; 84(1):101-7. PubMed ID: 24285605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol septal ablation in hypertrophic cardiomyopathy: an opportunity to be taken.
    Gimeno JR; Tomé MT; McKenna WJ
    Rev Esp Cardiol (Engl Ed); 2012 Apr; 65(4):314-8. PubMed ID: 22381943
    [No Abstract]   [Full Text] [Related]  

  • 9. Myectomy or alcohol septal ablation surgery and percutaneous intervention go another round.
    Heldman AW; Wu KC; Abraham TP; Cameron DE
    J Am Coll Cardiol; 2007 Jan; 49(3):358-60. PubMed ID: 17239718
    [No Abstract]   [Full Text] [Related]  

  • 10. Survival and pacemaker risk after alcohol septal ablation: informing the choice of invasive therapy for hypertrophic cardiomyopathy.
    Naidu SS
    Can J Cardiol; 2013 Nov; 29(11):1369-70. PubMed ID: 23890406
    [No Abstract]   [Full Text] [Related]  

  • 11. Selection of hypertrophic cardiomyopathy patients for myectomy or alcohol septal ablation.
    Lever HM
    Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():27-30. PubMed ID: 17162266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical septal myectomy versus alcohol septal ablation: assessing the status of the controversy in 2014.
    Maron BJ; Nishimura RA
    Circulation; 2014 Oct; 130(18):1617-24. PubMed ID: 25462821
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcome of patients after alcohol septal ablation with permanent pacemaker implanted for periprocedural complete heart block.
    Veselka J; Krejčí J; Tomašov P; Durdil V; Riedlbauchová L; Honěk J; Honěk T; Zemánek D
    Int J Cardiol; 2014 Feb; 171(2):e37-8. PubMed ID: 24360153
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effectivness of transcatheter alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy].
    Chernov SA; Kucherov VV; Fursov AN; Zakharova EG; Gaĭdukov AV; Liapkova NB; Korneev NV; Pestovskaia OR
    Voen Med Zh; 2009 Feb; 330(2):28-35. PubMed ID: 19351021
    [No Abstract]   [Full Text] [Related]  

  • 15. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Sorajja P; Ommen SR; Holmes DR; Dearani JA; Rihal CS; Gersh BJ; Lennon RJ; Nishimura RA
    Circulation; 2012 Nov; 126(20):2374-80. PubMed ID: 23076968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commentary and re-appraisal: surgical septal myectomy vs. alcohol ablation: after a decade of controversy and mismatch between clinical practice and guidelines.
    Maron BJ
    Prog Cardiovasc Dis; 2012; 54(6):523-8. PubMed ID: 22687595
    [No Abstract]   [Full Text] [Related]  

  • 17. Alcohol septal ablation: A useful tool in our arsenal against hypertrophic obstructive cardiomyopathy.
    Savarimuthu S; Harky A
    J Card Surg; 2020 Aug; 35(8):2017-2024. PubMed ID: 32652778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
    Ben-Dor I; Maluenda G; Wang Z; Lindsay J; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2012; 13(1):72-4. PubMed ID: 21296034
    [No Abstract]   [Full Text] [Related]  

  • 19. Tools & techniques: Alcohol septal ablation for hypertrophic cardiomyopathy.
    Bertog SC; Franke J; Hornung M; Hofmann I; Sievert H
    EuroIntervention; 2011 Dec; 7(8):1004-5. PubMed ID: 22157484
    [No Abstract]   [Full Text] [Related]  

  • 20. Treating hypertrophic cardiomyopathy: two views.
    Salberg L
    J Am Coll Cardiol; 2005 Dec; 46(11):2146; author reply 2146-7. PubMed ID: 16325059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.